ABSTRACT
INTRODUCTION
Glycodelin, formerly known as placental protein 14 and progesterone-associated endometrial protein, was originally extracted from human term placenta [1] . It is also present in the amniotic fluid [2] , endometrium [3] , ovary [4] , oviduct [5] , maternal serum [6] , and hematopoietic cells of the bone marrow [7] . The biological role of glycodelin-A is via its immunomodulatory activity in the maternal endometrium during implantation [8, 9] and its absence is characteristic of the fertile window [10] .
Glycodelin-F, also known as zona binding inhibitory factor-1 [11] , is a glycodelin isoform present in human follicular fluid [12] . Glycodelin-F has the same protein core as amniotic fluid glycodelin-A but with different oligosaccharide structure [12] . Although both glycodelin-F and -A inhibit sperm-zona pellucida binding [12, 13] , the former forms three complexes while the latter produces only two complexes with the soluble extract of human sperm [14] . Interestingly, solubilized zona pellucida proteins reduce the binding of glycodelin-F to human sperm extract, suggesting that the glycodelin-F binding sites and the zona pellucida protein receptors on human sperm are closely related [14] . Similar data on glycodelin-A is not available. Therefore, the first objective of this investigation was to determine the effect of zona pellucida protein on the binding of glycodelin-A to sperm extract.
Sperm-zona pellucida interaction is a critical step to fertilization. Its failure during the fertilization process accounts for some cases of male infertility [15, 16] . It is believed that, in mammals, sperm-zona pellucida interaction is carbohydrate mediated [17] [18] [19] [20] [21] [22] , with sperm recognizing specific oligosaccharides of the zona pellucida glycoproteins. The involvement of carbohydrate moieties in spermzona pellucida binding is demonstrated by a decrease in the number of N-acetylglucosamine-, D-mannose-, or L-fucosetreated sperms bound to the zona pellucida in hemizona binding assay [23] . Putative sperm and oocyte receptors have been studied in several species, including humans. The best characterized sperm receptor for the zona pellucida protein, ZP3, is ␤1,4-galactosyltransferase (GalT) that binds to the N-terminal N-acetylglucosamine residues on the oligosaccharide chains of ZP3. Oligosaccharides chains of ZP3 and synthetic polymers with N-acetylglucosamine terminal aggregate ␤1,4-galactosyltransferase on mouse sperms [21, 24] . ␣-D-mannosidase in rat and human [25, 26] and ␤-acetylglucosaminidase in human [27] [28] [29] have been suggested to be the sperm receptors for the mannosyl and N-acetylglucosamine residues, respectively, on the zona pellucida. Other potential zona pellucida receptors in mammalian sperm include fucosyltransferase [30] , sp17 [31] , PH-20 [32] , and sp56 [33] .
Selectins, including L-selectin (CD62L), E-selectin (CD62E), and P-selectin (CD62P), comprise a subfamily of Ca 2ϩ -dependent (C-type) animal lectins [34] and play important roles in cell-cell and cell-matrix interaction, such as during fertilization, implantation, embryogenesis, cell differentiation, and migration. They bind to various glycoconjugate ligands [35] . It has been suggested that the sialylLewis x(a) and the unusual fucosylated and sialylated GalNAc␤1, 4 GlcNAc (lacdiNAc) antennae of N-glycans in glycodelin-A with selectin ligand-like structure may participate in human sperm-zona pellucida interaction [36] .
Immunohistochemical data show that glycodelin-A and -F bind to the acrosomal region of human sperm [12] . Acrosome reaction leads to the loss of the outer acrosome membrane and plasma membrane of sperm. If the receptors for glycodelin isoforms are present on these membranes, then the use of reagents inducing acrosome reaction, e.g., neoglycoproteins [37, 38] and solubilized zona pellucida protein [39] , should affect their binding. Therefore, the second objective of this study was to determine the relationship between glycodelin-binding and acrosome reaction. The carbohydrate moieties of glycodelin-A and -F are important for their zona-binding inhibitory activity, and deglycosylated glycodelins have been shown to lose such activity in vitro [14] . Neoglycoproteins are synthesized by linkage of specific carbohydrate residues to a protein backbone. They have been used to investigate the impact of a given carbohydrate moiety in cell-to-cell interactions [40, 41] . The third objective of this study was to address the role of a single carbohydrate in neoglycoproteins and of selectins in the binding of glycodelin-A and -F to sperm. In this part, participation of the corresponding monosaccharide binding protein in sperm was demonstrated.
MATERIALS AND METHODS
The Ethics Committee of The University of Hong Kong approved the research protocol. Clinical samples were obtained from patients with informed consent.
Semen Samples
Semen samples with normal parameters [42] were from men visiting the subfertility clinics of the Queen Mary Hospital, University of Hong Kong. Sperm were separated by two-step Percoll (Pharmacia, Uppsala, Sweden) density gradient centrifugation. A Hettich centrifuge (Universal II, Hettich, Tuttlingen, Germany) was used for Precoll sperm preparation (300 g) and cell washing (150 g). After capacitating in Earle balanced salt solution (EBSS; Flow Laboratories, Irvine, UK) supplemented with sodium pyruvate, penicillin-G, streptomycin sulfate, and 3% bovine serum albumin for 3 h, Percoll-processed sperm were resuspended in EBSS containing 0.3% BSA (EBSS/BSA).
Human Follicular Fluid
Three hundred human follicular fluid samples were collected during oocyte retrieval from women attending the assisted reproduction program of the Queen Mary Hospital. After downregulation of the pituitary with gonadotroph-releasing hormone agonist, human menopausal gonadotroph and human chorionic gonadotroph were used for ovarian stimulation. Only follicular fluid samples with no blood contamination were used. In this study, the samples were pooled, filtered through a 0.22-m filter unit (Millipore, Bedford, MA) and stored at Ϫ20ЊC until used. Follicular fluid samples were thawed and diluted with EBSS/BSA to the desired concentration before use.
Purification of Glycodelin
The purification protocols of Chiu and coworkers [12] for glycodelin-A and -F were followed. Glycodelin-A was purified by mixing amniotic fluid with Triton X-100 (0.1%, v/v) and passing the mixture through a monoclonal anti-glycodelin antibody (clone F43-7F9) Sepharose column. The bound glycodelin-A was eluted with 0.1% trifluoroacetic acid. For glycodelin-F, follicular fluid was passed successively through Hi-Trap blue, protein-G, Con-A Sepharose columns (Pharmacia), Amicon-10 concentrator (Amicon Inc., Beverly, CA), Mono Q, and Superose columns. The concentrations of the purified glycodelins were determined by commercial assay kit (Bio-Rad Protein Assay; Bio-Rad, Hercules, CA).
Radioiodination of Glycodelin
Fifty micrograms of glycodelin in 0.02 ml of 0.05 M PBS (pH 7.4) was mixed with 2 mCi of sodium 125 I (20 l; Amersham Biosciences, Buckinghamshire, UK) and freshly prepared chloramine T (100 g in 0.02 ml of 0.05 M PBS, pH 7.4). After vortexing for 60 sec, sodium metabisulphite (300 g in 0.05 ml of 0.05 M PBS, pH 7.4) was added to stop the reaction. A desalting column was used to remove free 125 I. The first radioactive peak containing iodinated glycodelin was collected. Iodinated glycodelins had the same biological activity as their native form [14] .
Glycodelin-A Binding to the Human Sperm Extract
Solubilized human zona pellucida was prepared by separating the zona pellucida from oocytes using glass micropipettes and by heat solubilizing the zona at 70ЊC for 90 min in distilled water with pH adjusted to 9 with Na 2 CO 3 [14] . Soluble sperm extract was isolated as described [14] and divided into two identical portions (10 g protein/ml). Each portion was incubated with 1 g/ml of 125 I-glycodelin-A in the presence of zona pellucida protein at concentrations equivalent to 0 or 0.2 zona pellucida/l at 37ЊC for 3 h. After incubation, the mixtures were analyzed by nativegel electrophoresis and the radioactive band were visualized by exposing the gel to BIOMAX film (Kodak, Rochester, NY).
Determination of Acrosomal Status and Motility of Sperm
Fluorescein isothiocyanate labeled peanut (Pisum sativum) agglutinin (FITC-PSA; Sigma, St. Louis, MO) and Hoechst staining techniques were used to evaluate the acrosomal status of sperm as described [11] . The fluorescence patterns of 300 sperm in randomly selected fields were determined under a fluorescence microscope (Zeiss, Oberkochen, Germany) with 1000ϫ magnification. Sperm without Hoechst staining and without FITC-PSA staining or with FITC-PSA staining confined to the equatorial segment only were considered as acrosome-reacted sperm. Hobson Sperm Tracker System (Hobson Tracking Systems Ltd., Sheffield, UK) was used to determine the motility of sperm. The set-up parameters of the system and the procedures were described elsewhere [14] .
Effect of Acrosomal Status on Glycodelin Binding to Sperm
Percoll-processed sperm from five normospermic men were used in the series of experiments described below. The experiments were divided into three groups. One group (control) was incubated in 300 pmol/ml of 125 Iglycodelin-A or -F for 180 min at 37ЊC in an atmosphere of 5% CO 2 in air. Sperm in the other two groups were treated with ionophore A23187 (Sigma) for 30 or 180 min at 37ЊC under 5% CO 2 in air. A portion of the sperm from the two groups was incubated in EBSS alone in the corresponding conditions as control. After treatment, sperm were washed with fresh EBSS/BSA before being further incubated with 125 I-glycodelin-A or -F (300 pmol/ml) for 180 min. Sperm from different groups were then washed with fresh EBSS/BSA and their cell-bound radioactivity was measured in a gamma counter (model 5500B; Beckman, Fullerton, CA). The specific binding of glycodelin was determined by subtracting the bound radioactivity in the presence of 100ϫ concentration of unlabeled glycodelin from the bound radioactivity without unlabeled protein. The determination of total binding and nonspecific binding were done in triplicate. The acrosomal status was also determined as described above.
Glycodelin Binding on Fixed and Living Human Sperm
Results of the above experiment showed that ionophore-induced acrosome reaction reduced the binding of glycodelin to sperm (see below). To study the effect of neoglycoproteins on glycodelins binding, fixed sperm had to be used as neoglycoproteins might initiate acrosome reaction in live sperm. Fixation of sperm was performed by placing sperm briefly in 1% glutaraldehyde in EBSS for 5 min. To compare the glycodelinbinding ability of fixed and live sperm, sperm were washed thrice in fresh EBSS. Different concentrations of the sperm (0.01-10 ϫ 10 6 ) were incubated with 125 I-glycodelin-A or -F (300 pmol/ml) at 37ЊC in an atmosphere of 5% CO 2 in air for 3 h. The treated sperm were then washed with fresh EBSS/BSA and the cell-bound radioactivity was measured as described above. Competition-binding analysis was also performed to compare the binding kinetics of labeled glycodelin-A and -F in the presence of increasing concentrations of the corresponding glycodelin to fixed and unfixed sperm using the protocol described below. The results were 
Competition Binding Assay of Glycodelin with Neoglycoproteins
Competition binding assay was performed as described [14] . Briefly, the binding of labeled glycodelin (300 pmol/ml) to fixed human sperm (210 ϫ 10 6 /ml) was determined in the presence of increasing concentrations (0.3-30 000 pmol/ml based on monosaccharides) of neoglycoproteins, including bovine albumin p-aminophenyl-N-acetyl-␤-D-galactosaminide (BSA-GalNAc; Sigma), bovine albumin p-aminophenyl-N-acetyl-␤-D-glucosaminide (BSA-GlcNAc; Sigma), bovine albumin ␣-L-fucopyranosylphenyl isothiocyanate (BSA-Fuc; Sigma), bovine albumin p-aminophenyl-␣-D-mannopyranoside (BSA-Man; Sigma) or bovine albumin galactosamide (BSA-Gal; Sigma) at 37ЊC for 3 h. After incubation, the cell-bound radioactivity was measured with a gamma counter as described above. Under this condition, the bound radioactivity did not change in the absence of competitor within the experimental period (data not shown). Each individual experiment was repeated thrice.
Effect of Glycosidases and Their Inhibitors on Glycodelin Binding to Sperm
The above experiments demonstrated the involvement of monosaccharide residues in the binding of glycodelin to sperm. Enzyme inhibitors were used to confirm that the corresponding glycosidases were present on sperm. Sperm were incubated in 0.1, 0.5, and 1 mol/ml of deoxyfuconojirimycin (DFJ; ␣-L-fucosidase inhibitor [43] ), deoxygalactonojirimycin (DGJ; ␣-D-galactosidase inhibitor [44] ). 3,4,5,6-tetrahydroxy-azepane (THA; ␤-N-acetylglucosaminidase inhibitor [45] ), deoxymannojirimycin (DMJ; ␣-D-mannosidase I and ␣-L-fucosidase inhibitor [46] ), 1,4-dideoxy-1,4-imino-D-mannitol (DIM; mannosidase I and II inhibitor [47] ) (Industrial Research, Lower Hutt, New Zealand), uridine 5Јdiphosphogalactose disodium salt (UDP-Gal; galactosyltransferase inhibitor [48] ) and alphalactalbumin (LA; galactosyltransferase inhibitor; Sigma [49] ), or EBSS/ BSA (control) at 37ЊC under 5% CO 2 in air for 3 h. After incubation, sperm were treated with 300 pmol/ml of iodinated glycodelin-A or -F for 3 h and the cell-bound radioactivity was counted as described above. In addition, the ability of ␤1-2,3,4,6 linked N-acetyl-glucosaminidase (EC 3.2.1.52), ␣1-2,3,6-mannosidase (EC 3.2.1.24), ␣1-3,4-L-fucosidase (EC 3.2.1.51), and ␤-galactosidase (EC 3.2.1.23; Calbiochem, San Diego, CA) at concentrations of 0.5, 1, 2, and 3 g/ml to inhibit the binding of labeled glycodelin (300 pmol/ml) to fixed human sperm (210 ϫ 10 6 /ml) was performed. The effect of glycosidases or glycosidase inhibitors on sperm motility, viability, and acrosomal status were also studied.
Effect of Selectins on Glycodelin Binding to Sperm
Two experiments were performed to determine the role of E-selectin, L-selectin, and P-selectin (Calbiochem) in the binding of glycodelin to human sperm. The first experiment addressed the kinetics of competition binding of glycodelin isoforms in the presence of different concentrations (0.3-30 000 pmol/ml) of selectins using the protocol described above. The second experiment was on the effect of antiselectin monoclonal antibodies on iodinated glycodelin binding. In this experiment, sperm from five men were incubated with increasing concentrations (1-10 000 ng/ml) of monoclonal antiselectin (E, L, and P) antibodies (anti-E-and anti-L-selectin from Sigma; anti-P-selectin from Santa Cruz Biotechnology, Santa Cruz, CA) for 60 min at 37ЊC in an atmosphere of 5% CO 2 in air. After incubation, the sperm were washed with fresh EBSS/BSA followed by incubation with iodinated glycodelin-A or -F (300 pmol/ml) for 3 h. The cellbound radioactivity was then counted as described above. The effects of selectins and antiselectin antibodies on sperm motility, viability, and acrosomal status were studied.
Data Analysis
All the data were expressed as mean Ϯ standard error of the mean (SEM). The data and effective concentration in competition binding assay (EC 50 ) were analyzed using a Sigmastat statistical software (SigmaPlot 8.02, Ligand Binding Analysis Module and SigmaStat 2.03; Jandel Scientific, San Rafael, CA). For comparison of the effects of duration of ionophore treatment on the binding of glycodelin to sperm, the software determined that the data were normally distributed and repeated measure analysis of variance (ANOVA) was used followed by Tukey test as a post hoc test. For all other experiments, nonparametric ANOVA on rank was used for the multiple comparisons. Parametric Student t-test was subsequently used as a posttest and reported here because the statistical software confirmed that the data were normally distributed. Nonparametric MannWhitney U-test also were used as the posttest. The conclusions are identical to those using the parametric method (data not shown). A probability value Ͻ0.05 was considered to be statistically significant.
RESULTS

Effect of Solubilized Zonae Pellucidae on Binding of Glycodelin-A
The effects of solubilized zonae pellucidae on the binding of glycodelin-A to sperm extracts are shown in Figure  1 . Iodinated glycodelin-A (lane 1) showed a single radioactive band. Two additional radioactive bands appeared after incubation of glycodelin-A with the sperm extracts. All the additional bands had molecular sizes larger than that of iodinated glycodelin-A. Co-incubation of solubilized zona pellucida reduced the binding of glycodelin-A to one of the radioactive bands in the sperm extract (lane 3). Figure 2 shows the effect of calcium ionophore A23187-induced acrosome reaction on the binding of glycodelin isoforms to human sperm. Compared with control without ionophore, preincubation with A23187 for 30 and 180 min significantly reduced the specific binding of iodinated glycodelin-A and -F. Thirty minutes of treatment significantly increased (P Ͻ 0.05) the percentage of acrosome-reacted sperm from 9.6% Ϯ 1.5% to 34% Ϯ 2.1% and decreased the specific binding of 125 I-glycodelin-A by 62.0% Ϯ 4.1% and glycodelin-F by 42.3% Ϯ 6.2% compared with the con- trol. Prolongation of the incubation (180 min) increased the percentage of acrosome-reacted sperm to 54.2% Ϯ 2.0% and further reduced the 125 I-glycodelin-A and -F binding to 18.9% Ϯ 2.8% and 23.3% Ϯ 1.1% of the control, respectively (P Ͻ 0.05 for both).
Effect of Acrosomal Status on the Binding of Glycodelin to Sperm
Binding of Glycodelin to Live and Fixed Sperm
There was a linear relationship between the binding of 125 I-glycodelin-A (r 2 ϭ 0.96) and glycodelin-F (r 2 ϭ 0.91) and the number of fixed and unfixed sperm in the incubation mixture (Fig. 3) . The fractional binding (bound/free) was similar for the fixed and unfixed sperm. When the fixed sperm were incubated with saturating concentrations of 125 I-glycodelin-A (Fig. 4A) or 125 I-glycodelin-F (Fig. 4B ) in the presence of increasing concentrations of the corresponding unlabeled glycodelin, there was an exponential decrease in the binding of labeled molecules. Comparable effect was found with unfixed sperm. The log EC 50 of glycodelin-A on fixed and unfixed sperm were 2.19 Ϯ 0.7 and 2.19 Ϯ 0.07 pmol/ml, respectively. The corresponding values for glycodelin-F were 2.62 Ϯ 0.08 and 2.54 Ϯ 0.07 pmol/ml.
Competition Binding Analysis of Glycodelin with Neoglycoproteins
The effects of neoglycoproteins on the binding of 125 Iglycodelin to fixed sperm are shown in Figure 5 . As expected, unlabeled glycodelin was the best competitor for the corresponding iodinated glycodelin (log EC 50 : glycodelin-A, 2.17 Ϯ 0.07 pmol/ml; glycodelin-F, 2.48 Ϯ 0.08 pmol/ml). BSA alone had no effect. Among the neoglycoproteins, BSA-mannose and BSA-fucose competed with 125 I-glycodelin-A for binding sites, with log EC 50 of 3.69 Ϯ 0.08 pmol/ml and 4.07 Ϯ 0.07 pmol/ml, respectively, while the other neoglycoproteins did not affect the binding of labeled glycodelin-A except at high concentrations (log EC 50 Ͼ 5 pmol/ml; Fig. 5A ). Neoglycoprotein of N-acetylglucosamine, mannose, and fucose inhibited the binding of 125 I-glycodelin-F to similar extent, with log EC 50 of 4.38 Ϯ 0.03, 4.47 Ϯ 0.03, and 4.63 Ϯ 0.04 pmol/ml, respectively (Fig. 5B) . BSA-N-acetylgalactosamine and BSA-galactose were not effective in competing with glycodelin-F (log EC 50 Ͼ 5 pmol/ml). Figure 6 shows the effect of glycosidase inhibitors on glycodelin binding to human sperm. Among the inhibitors used, DIM had the greatest inhibitory effect on glycodelin-A binding. It dose-dependently inhibited the binding of glycodelin-A to human sperm (Fig. 6A ). Significant inhibition (P Ͻ 0.05) was found at the concentrations greater than 0.5 mol/ml. At 1 mol/ml, it inhibited 48.2% Ϯ 1.5% of the glycodelin-A binding. Glycodelin-A binding was also inhibited by DFJ and THA (P Ͻ 0.05) although with smaller magnitude, ranging from 10% to 20%. Deoxymannojirimycin (DMJ) inhibited glycodelin-A binding only at the concentration of 1 mol/ml. The binding of glycodelin-A was not affected by DGJ, UDP-Gal, and LA.
Effect of Glycosidase Inhibitors on Glycodelin Binding
While no significant inhibition was observed for UDPGal, DGJ, and LA, DIM and THA dose-dependently inhibited glycodelin-F binding (Fig. 6B ). Significant inhibition was found at the concentration of 0.5 mol/ml. The inhibitions of glycodelin-F binding at a concentration of 1 mol/ml of DIM and THA were 35.8% Ϯ 2.1% and 30.4% Ϯ 2.9%, respectively. At the same concentration, DFJ and DMJ only inhibited 10.6% Ϯ 1.6% and 11.4% Ϯ 1.3% of the binding, respectively. Their effects at lower concentrations were not different from the control without glycosidase inhibitor. The glycosidase inhibitors at the concentrations used did not affect sperm viability, acrosomal status, and motility (data not shown). 
Effect of Glycosidases on Glycodelin Binding
Mannosidase and fucosidase significantly inhibited the binding of glycodelin-A at 0.5 g/ml when compared with the control without glycosidase treatment (P Ͻ 0.05). At 3 g/ml, the inhibition was 54.7% Ϯ 3.5% and 34.7% Ϯ 3.2% of the maximal glycodelin-A binding, respectively (Fig.  7A) . The inhibition was dose dependent within the concentrations tested. No significant inhibition was observed with galactosidase and acetylglucosaminidase in any of the concentrations used.
Similar to glycodelin-A, mannosidase and fucosidase had the greatest inhibitory effect on glycodelin-F binding, with significant inhibition at a concentration of 0.5 g/ml (Fig. 7B) . The corresponding inhibition at 3 g/ml was 51.7% Ϯ 2.0% and 22.3% Ϯ 4.2%. Unlike that of glycodelin-A, acetylglucosaminidase inhibited glycodelin-F binding dose dependently; the inhibition was 43.7% Ϯ 2.8% at 3 g/ml. No inhibition was observed with galactosidase. At the concentrations employed, the glycosidases did not affect sperm viability, acrosomal status, and motility (data not shown).
Effects of Selectins E, L, and P on Glycodelin Binding to the Human Sperm
At a concentration of 1000 pmol/ml, E-selectin significantly inhibited (P Ͻ 0.05) the binding of glycodelin-A to sperm (Fig. 8A) . All other selectins (Fig. 8) and their monoclonal antibodies (data not shown) had no significant effects on the binding of glycodelin-A and -F to human sperm. The selectins and antiselectin antibodies used had no effect on sperm viability, acrosomal status, or motility (data not shown).
DISCUSSION
Solubilized zonae pellucidae protein dose-dependently reduces the binding of glycodelin-F to the sperm extract [14] . This report demonstrates that zona pellucida proteins also reduce the binding of glycodelin-A to sperm extract. Glycodelin-A and -F form two and three complexes, respectively, with sperm extract [14] . While the formation of two of the glycodelin-F complexes are inhibited by solubilized zona pellucida [14] , only one of the glycodelin-A complexes is affected by the zona pellucida proteins. These observations are consistent with the binding kinetic experiments demonstrating that human sperm possess two receptors for glycodelin-F, one of which is common with glycodelin-A [14] . Chiu and coworkers [14] also suggest that glycodelins and zona pellucida proteins may bind to the same receptor(s) or that their receptor(s) are closely related so that the binding of one would affect binding of the other.
Sperm bind to zona pellucida with the acrosomal region, and glycodelin-A and -F bind to the acrosomal region of sperm [12] . The present study demonstrates that the glycodelin-binding sites are on the outer acrosomal membrane or in the sperm plasma membrane overlying the acrosome, as the binding of glycodelin isoforms to sperm was greatly reduced after ionophore-induced acrosome reaction. These observations lend support to the close relationship between glycodelin receptor(s) on sperm and zona pellucida proteins.
Neoglycoproteins are frequently used in studies on sperm-zona pellucida interactions, some of which mimic the action of ZP3 glycoprotein and induce acrosome reaction in capacitated mouse [28, 40] and human sperm [50] . The acrosome reaction-inducing ability of neoglycoprotein and the reduction of glycodelin binding after acrosome reaction requires the use of fixed, instead of live, sperm for characterization of the glycodelin-binding sites on sperm using neoglycoproteins; otherwise, equilibrium binding would have been impossible to achieve. The fixed cell model has been used successfully to characterize mouse spermzona pellucida interaction [51] . The suitability of this model in this study was demonstrated by sperm concentration-dependent binding of 125 I-glycodelin to fixed sperm, and by the comparable binding kinetics of glycodelin isoforms with fixed and live sperm.
It has been proposed that sperm-zona pellucida recognition is mediated by a number of complementary proteins and carbohydrate structures on the surface of sperm and oocytes [17] [18] [19] [20] [21] [22] 24] . Even though several carbohydratebinding proteins have been proposed to be involved in sperm-oocyte interaction [22, 25, 26, 30, [52] [53] [54] , the exact identity of the sperm surface protein(s) responsible for sperm-zona pellucida binding remains unresolved.
The carbohydrate moieties of glycodelin-A and -F are critical for their zona-binding inhibitory activity as well as their binding on human sperm, and deglycosylated glycodelin loses such activities in vitro [14] . Glycodelin-F has the same protein core as glycodelin-A, but their oligosaccharide chains are different [12] . In the present study, we demonstrated that different sets of carbohydrate residues affected the binding of these glycodelin isoforms to sperm. While the binding of glycodelin-A appears to be affected by the mannose and fucose residues, that of glycodelin-F is influenced by N-acetylglucosamine in addition to fucose and mannose. This is in keeping with the observation that both glycodelin isoforms have similar lectin-binding spectrum except that glycodelin-F binds more strongly to wheat germ agglutinin and its succinylated form with specific affinity for N-acetylglucosamine residue [12] .
Mannose and fucose neoglycoprotein suppress the binding of radiolabeled glycodelin-A to human sperm to a greater extent than that of glycodelin-F. One possible explanation is that glycodelin-F has an additional high-affinity binding site on sperm when compared with glycodelin-A [14] . This may make it more difficult for the neoglycoproteins to compete with glycodelin-F for the binding sites. It is also possible that the contribution of mannose and fucose residues in the binding of glycodelin-F to sperm is smaller than that in glycodelin-A sperm binding. The present data do not allow us to distinguish between these possibilities.
The involvement of mannose and N-acetylglucosamine residues in glycodelin binding is supported by the ability of mannosidase and acetylglucosaminidase and their inhibitors to inhibit glycodelin sperm binding. Both DIM and DMJ are mannosidase inhibitors. DIM inhibited but DMJ had only marginal effect on glycodelin binding to sperm. 1,4-dideoxy-1,4-imino-D-mannitol (DIM) is an inhibitor of mannosidase I and II [47] , while DMJ is a mannosidase I and ␣-L-fucosidase inhibitor [46] . Mannosidase I acts specifically on ␣1-2-linked mannose residues and mannosidase II is specific for ␣1-3-linked and ␣1-6-linked mannose residues. Therefore, it is possible that the ␣1-3 and/or ␣1-6 mannose residue in the glycan chain of glycodelin participate in sperm binding.
Rat, mouse, hamster, and human sperm possess mannosidase activity [25, 55] . Mannosidase binds and hydrolyses terminal mannose of N-linked oligosaccharides. Alpha-mannosidase activity has been localized to the plasma membranes of rat [25] , mouse [26] , and human sperm [55] . However, the exact mannosidase isoform on sperm remains to be identified. The importance of mannosyl residues in fertilization is demonstrated by the observation that incubation of mouse sperm with D-mannose results in a dosedependent decrease in the number of sperm bound to the oocyte [56] . Pretreatment of human sperm with D-mannose also inhibits sperm penetration through the zona [57] .
Acetylglucosaminidase and its inhibitor affect the binding of glycodelin-F to human sperm but not that of glycodelin-A. Glycodelin-F has a high-affinity receptor that is not shared with glycodelin-A [14] . Thus, the binding of glycodelin-F to the high-affinity receptor may involve Nacetylglucosamine residue. The importance of N-acetylglucosamine residues in human sperm function has been reported [23, 27, 28, 38] . N-acetylglucosamine reduces the binding of capacitated human sperm to the zona pellucida [23] . This is supported by the observation that acetylglucosaminidase, which hydrolyses the terminal N-acetylglucosamine of the glycan, reduces the number of human sperm bound to the zona pellucida [27] . Although N-acetylglucosaminidase also hydrolyses N-acetylgalactosamine residue, this monosaccharide residue is unlikely to be involved in the binding of glycodelin to sperm, as its neoglycoprotein did not affect glycodelin binding in the present study. This is consistent with previous observations that neither this monosaccharide nor its neoglycoprotein affects sperm-zona pellucida binding [27] or acrosomal status of the human sperm in vitro [28] .
In this study, the contribution of fucose residues in the binding of glycodelin varied depending on the assays performed. Fucose-neoglycoprotein and fucosidase suppressed but fucosidase inhibitor only marginally inhibited the binding of glycodelin-A and -F to sperm. Plasma membraneassociated ␣-L-fucosidase has been found on sperm of different species, including rat [58] and human [59] . L-fucosyl-binding sites have also been reported on intact [41] and acrosome-reacted [60] human sperm. Fucose-neoglycoprotein binds primarily to the sperm head, which could be inhibited by solubilized human zona pellucida proteins [41] . The reason for the lack of effect of fucosidase inhibitor on glycodelin binding is unknown. It could be that the fucosidase in sperm is different from that in the other cells or that the fucose-binding site in sperm is not due to fucosidase, thus making the inhibitor ineffective in suppressing the glycodelin binding to sperm. Beta-1,4-galactosyltransferase is the best characterized potential sperm receptor for zona pellucida. It binds specifically to the N-terminal N-acetylglucosamine residues of ZP3 but not to the other zona pellucida proteins [24, 61] . The enzyme is present in the head region of all mammalian sperm studied, including human, consistent with a role in gamete recognition [24, 49, 62, 63] . Reagents blocking the activity of the enzyme, including UDP-Gal and alpha-lactalbumin, inhibit sperm-zona pellucida binding [24, 49, 64] . In this study, both UDP-Gal and alpha-lactalbumin did not affect the binding of glycodelin-A and -F to human sperm. These observations suggest that, although glycodelin-A and -F inhibit sperm-zona pellucida binding [12, 13] , the binding of glycodelins to sperm differs from that of the zona pellucida in that the former does not involve galactosyltransferase activity.
Glycodelin-A contains N-glycans with selectin-like ligands, e.g., sialyl-Lewis x(a) and fucosylated and sialylated lacdiNAc-antennae [22, 36] . Recently, glycodelin-A has been reported to inhibit E-selectin-mediated cell adhesion [65] . Using purified selectins and antiselectin antibodies, we demonstrated that the binding of glycodelin-F was independent of selectins. On the other hand, E-selectin had slight inhibitory effect on the binding of glycodelin-A to sperm. These results are consistent with previous conclusions that glycodelin-F and glycodelin-A have different oligosaccharide chains [12] . However, the inability of antiselectin antibody to affect the binding of glycodelin-A to sperm suggests that sperm protein(s) with selectin-like activity, but not selectin, is involved in the sperm binding. A similar conclusion was reached for the binding of sperm to the zona pellucida [22] .
The present data show that no single residue, even at high concentration, could produce a complete blockade of glycodelin binding to sperm, suggesting that the interaction of glycodelin with the sperm receptor is multivalent, involving several residues and possibly several receptor complexes. Such a multivalent binding would strengthen the protein-oligosaccharide interaction, even if the individual monosaccharide-protein interactions appeared weak [66] . Multivalent ligand binding exists between the L-and Pselectin proteins and sialyl Lewis-X [67] . This is in agreement with the suggestion that sperm-zona pellucida interaction is a complex event involving interaction of multiple sperm proteins with multiple sugar residues of the zona pellucida protein(s) [66] .
In summary, the binding of glycodelin-A to sperm involves mannose, fucose, and possibly E-selectin-binding residues, while that of glycodelin-F involves mannose, fucose, and N-acetylglucosamine. The reduction in glycodelin binding after acrosome reaction and the ability of the zona pellucida to displace glycodelin from sperm extract suggest a close relationship between glycodelin receptors and zona pellucida protein receptors. However, a difference in the requirement for the binding of glycodelin and zona pellucida to sperm is noted when comparing the present study with previous reports [24, 49, 64] . While the binding of zona pellucida proteins requires galactosyltransferase, the enzyme activity is not needed for glycodelin binding, indicating that the receptors for glycodelin and zona pellucida proteins are not identical. It has been suggested that the receptors of zona pellucida proteins in sperm are complexes comprised of a number of molecules [17, 19, 21, 68] . Whether the glycodelin isoforms exert their sperm-zona binding inhibitory activity by blocking part of the zona pellucida receptor complexes awaits further investigation.
